|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
9 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Accretion of deferred loan origination fees and other discounts | |||||
| Paid-in-kind interest | |||||
| Change in unrealized gain/loss on debt securities, at fair value | |||||
| Realized gain on debt securities | |||||
| Interest received through net settlement transactions | |||||
| Provision (benefit) for current expected credit losses | |||||
| Change in unrealized (gain) loss on investments | |||||
| Realized gain on debt securities, at fair value | |||||
| Amortization of debt issuance costs | |||||
| Stock based compensation | |||||
| Changes in operating assets and liabilities: | |||||
| Interest receivable | |||||
| Other receivables and assets, net | |||||
| Interest reserve | |||||
| Related party payables | |||||
| Related party receivables | |||||
| Purchase of debt securities, at fair value | |||||
| Proceeds from the redemption of debt securities, at fair value | |||||
| Management and incentive fees payable | |||||
| Interest payable | |||||
| Accounts payable and accrued expenses | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Issuance of and fundings of loans held for investment | |||||
| Principal repayment of loans held for investment | |||||
| Principal repayment of loans held at fair value | |||||
| Issuance of and fundings of loans at fair value | |||||
| Proceeds from sale of loans | |||||
| Net cash provided by/(used in) investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from sale of common stock | |||||
| Proceeds from notes payable | |||||
| Proceeds from borrowings on revolving loan | |||||
| Repayment of borrowings on revolving loan | |||||
| Dividends paid to common shareholders | |||||
| Payment of debt issuance costs | |||||
| Payment of offering costs | |||||
| Net cash (used in)/provided by financing activities | |||||
| Net (decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Supplemental disclosure of non-cash financing and investing activities | |||||
| Interest reserve withheld from funding of loan | |||||
| Interest reserve withheld from funding of loans | |||||
| OID withheld from funding of loans held for investment | |||||
| OID withheld from funding of debt securities, at fair value | |||||
| Dividends declared and not yet paid | |||||
| Transfer of loans held for investment to loans held for sale | |||||
| Non-cash exchange of loans with related party (Note 9) | |||||
| Supplemental information: | |||||
| Interest paid during the period | |||||
Loading...